XML 21 R7.htm IDEA: XBRL DOCUMENT v3.7.0.1
Consolidated Statements of Cash Flow - USD ($)
$ in Thousands
12 Months Ended
Jul. 31, 2017
Jul. 31, 2016
Jul. 31, 2015
Cash flows from operating activities:      
Net Income (Loss) Available to Common Stockholders, Basic $ 394,261 $ 270,360 $ 219,783
Adjustments to reconcile net income to net cash provided by operating activities:      
Depreciation and amortization, including debt cost 57,441 49,643 48,893
Allowance for doubtful accounts 187 1,175 (578)
Impairment of long-lived assets 19,365 0 0
Equity in losses of unconsolidated affiliates 671 895 0
Stock-based payment compensation 20,840 20,864 18,154
Excess tax benefit from stock-based payment compensation 0 0 (2,971)
Loss (gain) on sale of property and equipment 184 (54) (918)
Deferred income taxes 19,901 5,740 4,365
Changes in operating assets and liabilities, net of effects from acquisitions:      
Accounts receivable (38,542) (54,213) (20,417)
Vehicle pooling costs (1,915) (4,137) (891)
Inventories 1,294 (2,509) (1,731)
Prepaid expenses and other current assets 1,760 (738) 69
Other assets 1,085 4,164 10,125
Accounts payable and accrued liabilities 4,269 48,347 (3,926)
Deferred revenue 392 983 (438)
Income taxes receivable 12,343 (12,649) (806)
Income taxes payable (333) 2,788 (1,971)
Other liabilities (1,145) 1,839 (1,666)
Net cash provided by operating activities 492,058 332,498 265,076
Cash flows from investing activities:      
Purchases of property and equipment (172,178) (173,917) (79,153)
Proceeds from sale of property and equipment 660 562 1,521
Proceeds from sale of assets held for sale 105 100 217
Investment in unconsolidated affiliate (3,566) 0 (4,500)
Purchases of assets and liabilities in connection with acquisitions, net of cash acquired (160,812) 0 0
Purchases of marketable securities 0 (21,119) 0
Proceeds from sale of marketable securities 0 21,498 0
Net cash used in investing activities (335,791) (172,876) (81,915)
Goodwill impairment losses 21,800 21,800  
Cash flows from financing activities:      
Proceeds from the exercise of stock options 31,188 13,240 3,634
Excess tax benefit from stock-based payment compensation 0 0 2,971
Proceeds from the issuance of Employee Stock Purchase Plan shares 4,270 3,369 3,079
Repurchases of common stock 0 (442,855) (233,484)
Payments for employee stock-based tax withholdings (135,433) (15,039) (3,822)
Proceeds from the issuance of long-term debt, net of discount 0 93,468 698,939
Net (repayments) proceeds on revolving loan facility (7,000) 238,000 0
Debt offering costs 0 (1,179) (955)
Principal payments on long-term debt 0 (337,500) (350,000)
Net cash (used in) provided by financing activities (106,975) (448,496) 120,362
Effect of foreign currency translation 4,959 (11,289) (6,179)
Net increase (decrease) in cash and cash equivalents 54,251 (300,163) 297,344
Cash and cash equivalents at beginning of period 155,849 456,012 158,668
Cash and cash equivalents at end of period 210,100 155,849 456,012
Supplemental disclosure of cash flow information:      
Interest paid 23,221 23,606 18,121
Income taxes paid, net of refunds $ 14,011 $ 127,981 $ 109,925